New Market Research Report: DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2014 Update

Boston, MA -- (SBWIRE) -- 06/06/2014 -- DexCom, Inc. (DexCom) is a medical device company. It undertakes the design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. Its major products include DexCom G4 Platinum, DexCom G4 Platinum (Pediatric) and DexCom Seven Plus continuous glucose monitoring systems. The company's in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also offers DexCom Studio software to download reports; and DexCom mobile application on iOS and Android platform. The company also offers data transfer services through its subsidiary SweetSpot Diabetes Care, Inc. DexCom is headquartered in San Diego, California, the US.